The World’s Foremost Source of Medicinal Product Information

Accurate medicinal product information – quickly and correctly communicated – is vital for many organizations active in life sciences – both commercial and regulatory agencies. The Uppsala Monitoring Centre (UMC) is today the first-choice source of medicinal product information for both user groups – a global hub of products, services and scientific research focused on clinical data and patient safety. 

 

The unique codes and classifications of our flagship product – the WHO Drug Dictionary Enhanced (WHO DDE) – assist Pharmaceutical Companies and CROs to set up clinical studies, interpret concomitant medication, analyze the data, and submit the results.
Our VigiBase™ database of more than seven million adverse reaction reports gathered from over 100 countries is the world’s largest collection of drug safety information.
WHO-ART (WHO Adverse Reaction Terminology) helps WHO Program member countries and commercial groups code clinical information in relation to drug therapy.
The UMC introduces the Drug Dictionary China, which converts Chinese character medicinal product names into WHO DDE’s global coding system to reveal information vital to pharmaceutical development projects.




Share this